Diaper Rash | Determination of Safety and Consumers' Satisfaction of Moussik Versus Desitin Creamy Ointment in Diaper Rash Prophylaxis

Diaper Rash research study

What is the primary objective of this study?

The purpose of this clinical observation is to evaluate the safety and consumers' satisfaction of Moussik vs Desitin Creamy ointment as a diaper rash protection product.

Who is eligible to participate?

Inclusion Criteria: - Healthy male or female infants aged between 3-18 months who are routine users of disposable diapers Exclusion Criteria: - Children with symptoms of systemic disease or skin lesions. - Children diagnosed as having diaper dermatitis at baseline - Known hypersensitivity to any of the components of the trial preparations. - Children suffering from atopic diseases. - Children who have participated during the last month in another clinical trial.

Which medical condition, disease, disorder, syndrome, illness, or injury is researched?

Diaper Rash

Study Interventions

Interventions can include giving participants drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available or noninvasive approaches such as surveys, education, and interviews.

Other:Moussik Diaper Rash MousseTo be used as instructed

Other:Desitin Creamy OintmentTo be used as instructed

Study Arms

Research studies and clinical trials typically have two or more research arms. An arm is a group of people who receive the same treatment in the study.

Study Status


Start Date: January 2013

Completed Date: December 2013

Phase: Phase 4

Type: Interventional


Primary Outcome: Six point erythema skin grade

Secondary Outcome: Visual analogue scale (VAS) from 0 to 10

Study sponsors, principal investigator, and references

Principal Investigator: Kobi Shiff, MD

Lead Sponsor: Trima, Israel Pharmaceutical Products


More information:

Discuss Rash